Ligand Pharmaceuticals reported $24K in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
Amgen USD 56.2B 1.18B Jun/2025
Arrowhead Research USD 388.24M 21.18M Mar/2025
Baxter International USD 10.31B 2.82B Mar/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Glaxosmithkline GBP 17.35B 368M Jun/2025
Insmed USD 564.1M 567.29M Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
Ligand Pharmaceuticals USD 24K 0 Mar/2025
MacroGenics USD 37.25M 37.25M Jun/2025
Merck USD 34.84B 2.27B Mar/2025
Pacira USD 580.49M 2.88M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
Veracyte USD 50.5M 50.5M Mar/2025